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SUMMARY
Phosphorylation sites often have key regulatory functions and are central to
many cellular signaling pathways, so mutations that modify them have the poten-
tial to contribute to pathological states such as cancer. Although many classifiers
exist for prioritization of coding genomic variants, to our knowledge none of
them explicitly account for the alteration or creation of kinase recognition motifs
that alter protein structure, function, regulation of activity, and interaction net-
works through modifying the pattern of phosphorylation. We present a novel
computational pipeline that uses a random forest classifier to predict the patho-
genicity of a variant, according to its direct or indirect effect on local phosphor-
ylation sites and the predicted functional impact of perturbing a phosphorylation
event. We call this classifier PhosphoEffect and find that it compares favorably
and with increased accuracy to the existing classifier PolyPhen 2.2.2 when tested
on a dataset of known variants enriched for phosphorylation sites and their neigh-
bors.
INTRODUCTION
Mutations in the coding region of the human genome can contribute to pathological phenotypes through
their molecular effect on the structure and function of proteins. Althoughmany genetic diseases are caused
by well-characterized mutations in single genes, others, such as cancer, are complex polygenic conditions
resulting from the accumulation of numerous genomic mutations, with different cancers exhibiting a wide
variety of mutational patterns.
In the post-genomic era, next-generation sequencing (NGS) platforms such as Illumina and IonTorrent can
generate huge amounts of sequence data and identify millions of variants in a single genome (Zhang et al.,
2011). This can facilitate the identification of pathogenic mutations in tumors and aid in their prediction,
diagnosis, prognosis, and intervention, as well as guide in the design of novel targeted drugs (Torshizi
and Wang, 2018). However, the majority of mutations in any cancer genome are benign, so-called passen-
ger mutations, which arise by chance andmay hitchhike to fixation if they co-occur withmutations beneficial
to the growth of the tumor, the so-called driver mutations. Distinguishing driver from passenger mutations
has been the holy grail of cancer diagnosis and treatment (Pon and Marra, 2015).
Recent developments in machine learning algorithms, which can predict the impact of mutations on pro-
tein structure and/or function and ‘‘prioritize’’ them based on clinical relevance have indeed come to the
rescue of cancer diagnosis and treatment. These algorithms include PolyPhen (Adzhubei et al., 2010),
SIFT (Sorting Intolerant From Tolerant; Sim et al., 2012), FATHMM (Functional Analysis Through Hidden
Markov Models; Rogers et al., 2018), CADD (Combined Annotation Dependent Depletion; Rentzsch
et al., 2018), and MutationTaster (Schwarz et al., 2014). Their predictions are based on a wide range of fea-
tures including sequence context, conservation, and predicted impact on protein structure. They also take
into account post-translational modifications (PTMs), such as phosphorylation, as these can regulate the
structure, function, and interaction partners of a protein and play important roles in cellular signaling (Ar-
dito et al., 2017).
Mutations that perturb PTMs—for instance, substituting a phosphorylation site for a residue that cannot be
phosphorylated— can have a significant impact on the function of a protein and/or the regulation of its
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activity (Radivojac et al., 2008). Efforts have therefore been made to catalog missense variants that map to
phosphorylation sites, for instance, AWESOME (AWebsite Exhibits SNPOnModification Event; Yang et al.,
2019), ActiveDriverDB (Krassowski et al., 2018), and MIMP (Mutation Impact on Phosphorylation, Wagih
et al., 2015). Similar attempts have been made for ubiquitination with some experimental validation (Mar-
tı´nez-Jime´nez et al., 2020).
However, not all phosphorylation sites are necessarily functional, and the regulatory importance of phos-
phorylation sites can vary greatly. Several studies have therefore aimed to classify functional versus
nonfunctional phosphorylation sites according to features such as sequence context, conservation, and
structure (Beltrao et al., 2012; Xiao et al., 2016). Additionally, residues of neighboring phosphorylation sites
can influence the degree of phosphorylation, since protein kinases largely recognize short linear motifs sur-
rounding the target residue. Thus, mutations in the flanking region of phosphorylation sites have the po-
tential to greatly influence protein structure and function by up- or downregulating the stoichiometry of
phosphorylation at that site. However, as far as we are aware, existing variant classifiers do not explicitly
consider these effects.
Additionally, given that protein phosphorylation frequently modifies protein-protein interaction (PPI) part-
ners and this modification is central to many, if not most, cellular signaling pathways, another important
consideration is the impact of disrupting or altering phosphorylation sites on its PPI, and indeed on the
whole PPI network. The study of molecular interaction networks has become increasingly applied to human
diseases such as cancer, with the effect of many known cancer mutations being understood through their
effect on PPI networks (Hijazi et al., 2020; Creixell et al., 2015). But one of themajor shortcomings of existing
phosphorylation classifiers in our view is their failure to take such network information into account and
implement them in the algorithm.
Finally, variant prioritization algorithms generally consider sequence conservation as a key feature, based
on the reasoning that mutations in highly conserved regions have undergone negative selection and are
thus most likely deleterious. However, this may penalize against pathogenic variants that are on or adjacent
to phosphorylation sites, since these are enriched in disordered regions that are generally poorly
conserved (Krassowski et al., 2018).
In light of this, we sought to develop a classifier that built upon existing algorithms for prioritizing variants
but included a greater range of features describing the effect of a mutation on protein structure and func-
tion, as well as the broader PPI network, through its effect on direct and/or neighboring phosphorylation
sites. We collected and annotated a set of variants of known clinical significance, then used the annotated
features to train and test a random forest-based classifier. We find that the classifier, which we call Phos-
phoEffect, compares favorably to PolyPhen. We thus present a user-ready, open-source pipeline that
can take as input a list of single amino acid point mutations and output the predicted probability that
each mutation is pathogenic.
RESULTS
Enrichment of Mutations around Phosphorylation Sites
We retrieved all annotated human phosphosites from PhosphoSitePlus (Hornbeck et al., 2015), a compre-
hensive database of PTMs curated from UniProtKB and published experimental datasets. These were
mapped onto missense mutations derived from the COSMIC (Catalogue Of Somatic Mutations In Cancer)
database, a comprehensive, manually curated genomic data repository for human cancers (Tate et al.,
2019). As described in the Methods section, we took a sample of 100 tumors of each of the main tumor
types in the dataset of whole-genome/whole-exome sequence studies, containing a total of 282,019 single
amino acid mutations. We evaluated the frequency of mutations on and around phosphorylation sites to
test for enrichment (Figure 1). We found that mutations were underrepresented in phosphorylation sites
(hypergeometric test, fold enrichment = 0.94, Benjamini-Hochberg (BH)-corrected p = 1.60 3 105). In
contrast, mutations were significantly overrepresented at positions 4, 3, 2, 1, and +1 (fold-enrich-
ments 1.06, 1.14, 1.03, 1.08, and 1.05 respectively, all BH-corrected p values < 0.05), whereas there was
no significant enrichment in either direction at the remaining positions (Table 1).
We hypothesized that mutations on phosphorylation sites are underrepresented because they are more
likely to abolish the phosphorylation site altogether and be deleterious, whereas mutations in the
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neighborhood of phosphorylation sites that alter the binding affinity of kinases and/or phosphatases may
fine-tune the level of phosphorylation and lead to deregulated protein function, rationalizing their overen-
richment in tumors.
Evaluating the Success of Existing Predictors on Variants Affecting Phosphorylation Sites
Existing predictors such as PolyPhen do not take into account the effect of mutations on residues of neigh-
boring phosphosites nor do they explicitly consider the network-rewiring effect of mutations affecting
phosphorylation. We assessed the performance of PolyPhen on three classes of variants: mutations
mapping to phosphorylation sites (class 1), mutations that are not directly phosphorylated but are within
five residues of a phosphorylation site (class 2), and mutations that have no phosphorylation sites in
Figure 1. Enrichment of Mutations in the Vicinity of Phosphorylation Sites in Human Cancers
The solid red line shows the expected number of mutations at each site, whereas the dotted lines are the upper and lower
2.5% bounds of the corresponding hypergeometric distribution, respectively.
Site Relative to
Phosphosite
Fold Enrichment of
Mutations
BH-Corrected p Value
5 1.02 0.126
4 1.06 6.86 3 106
3 1.14 2.42 3 108
2 1.03 1.79 3 102
1 1.08 3.08 3 108
0 0.94 1.60 3 105
1 1.05 3.54 3 104
2 1.03 4.74 3 102
3 1.01 0.632
4 1.01 0.662
5 1.01 0.296
Table 1. Enrichment of Mutations in the Vicinity of Phosphorylation Sites in the COSMIC CancerMutation Database
All hypergeometric test p -values are Benjamini-Hochberg corrected for multiple testing.
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the +-5 region (class 3) (Figure 2). A total of 21,037 variants of known clinical significance were retrieved
from the ClinVar database as described in the Methods section. Of these, 450 were classified as class 1,
3,452 were class 2, and 17,135 were class 3. PolyPhen classifies variants as ‘‘probably damaging’’ (false pos-
itive rate <10%), ‘‘possibly damaging’’ (false positive rate 10%–20%), or benign (false-positive rate >20%).
For the purpose of the following evaluation we are classifying predictions of ‘‘probably damaging’’ or
‘‘possibly damaging’’ as pathogenic.
We found that PolyPhen had the highest sensitivity on the class 3 variants, with a true positive rate of 88%
indicating that 12% of pathogenic variants were incorrectly classified as benign. In contrast, 16% of path-
ogenic class 1 variants and 17% of pathogenic class 2 variants were classified as benign. A chi-square
test indicated a significant difference between the three proportions (chi-square = 39.67, df = 2, p =
2.43 3 109). In ad hoc pairwise testing the only significant difference was between class 2 and class 3
(chi-square = 36.97, df = 1, BH-corrected p = 7.193 109, Table S1). This indicates that PolyPhen has a ten-
dency to underestimate the pathogenicity of mutations that occur in the neighborhood of phosphorylation
sites.
In regard to specificity, the false-positive rate was 25% for class 1 variants, 23% for class 2, and 26% for class
3. The differences between the groups were marginally significant (chi-square = 6.18, df = 2, p = 0.0455),
and ad hoc pairwise testing showed a marginally significant difference between class 2 and class 3 (chi-
square = 6.02, df = 1, p = 0.424, all p values BH corrected for multiple testing). However, the effect size
is small and the significance of this difference, if any, is unclear.
The Influence of Mutations on Kinase Recognition Motifs
To test the hypothesis that mutations in the neighborhood of phosphorylation sites could contribute to dis-
ease by altering or creating kinase recognition motifs, and thus modifying the strength or regulation of
phosphorylation sites, we needed a metric to predict the strength of phosphorylation at a site as a function
of its sequence context. To this end, we used the NetPhorest classifier (Horn et al., 2014) as described in the
Feature Source
Molecular weight of wild-type residue (Da)
Molecular weight of mutant residue (Da)
Chemical property of wild-type residue
(acidic, basic, polar, nonpolar)
Chemical property of mutant residue
Polyphen score Polyphen 2.2.2 (Adzhubei et al., 2010)
Secondary structure (helix, sheet,
disordered, other)
RING (Piovesan et al., 2016)
Wild-type residue phosphorylated? PhosphoSitePlus (Hornbeck et al., 2015)
Number of phosphorylated neighbors (+-5) PhosphoSitePlus
Impact on phosphorylation level Derived from NetPhorest (Horn et al., 2014)
Network perturbation score Derived from iPTMnet (Huang et al., 2018)
and
STRING database (Szklarczyk et al., 2019)
Number of internal contacts (of neighboring
phosphorylated residues)
RING
RAPDF (of neighboring phosphorylated
residues)
RING
Table 2. Features Used to Train the Classifier
RAPDF, residue-specific all atom-dependent conditional probability distribution function, RING, residue interaction network
generator.
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Methods section and derived a score as the sum of the probabilities that a site would be phosphorylated by
each possible class of kinase.
To illustrate this, an example is shown of p53 (Figure 3), one of themost commonly mutated genes in human
cancers (Muller and Vousden, 2013). The residue Ser20 is itself phosphorylated and also lies just down-
stream of two other phosphosites, Ser15 and Thr18. A point mutation at this position therefore has the po-
tential to have a triple effect on the phosphorylation stoichiometry of the protein.
Figure 3 shows the NetPhorest predictions for these three residues in the wild-type and in two different
point mutants: serine to tyrosine (S20Y), which can also be phosphorylated, and serine to proline (S20P),
which abrogates phosphorylation at this position. Neither mutation affects the sole ATM/ATR kinase
recognition motif of Ser15, so the score on this phosphorylation site would be 0 for both mutants. In
contrast, the other two phosphosites are altered by both mutations. S20Y increases the summed strength
for Thr18 phosphorylation from 1.03 to 1.1, so has a score of 0.07 on this site, whereas Tyr20 has a summed
strength of 0.85 compared with 0.53 on Ser20, a score of 0.32. This results in a total score of 0.39 for the S20Y
mutant, reflecting its impact on the strengths of direct and neighboring phosphosites.
The less conservative S20P mutant reduces the strength of Thr18 phosphorylation to 0.85 and completely
abolishes the Ser20 phosphorylation as proline lacks the phosphorylatable hydroxyl group. The total score
for S20P is therefore |(0.85-1.03)| + |(0-0.53)| = 0.71, representing a bigger impact of this mutation on the
surrounding phosphorylation pattern.
This procedure was applied to the class 2 variants, as described in the previous section, to determine
whether there was a correlation between the impact of a variant on local phosphorylation sites and its path-
ogenicity. The mean score of the pathogenic variants was 0.21, whereas that of the benign variants was 0.20
(Mann-Whitney U = 1,429,324, n1 = 1,575, n2 = 1,877, p = 0.047, Figure S1). Although only marginally sig-
nificant, this supports our hypothesis that deleterious variants are slightly more likely to influence local
phosphorylation patterns than benign ones, and so this impact score was used as a feature for training
the classifier. Additionally, since some mutations have multiple phosphorylation sites in their flanking re-
gions, structural and functional features of neighboring phosphosites that were used to estimate the
impact of perturbing phosphorylation were weighted according to the predicted impact of the mutation
on that phosphosite, as detailed in the Methods section.
Performance of the Random Forest Classifier
A random forest classifier, which we call PhosphoEffect, was trained on a training set of 2,274 benign and
2,400 pathogenic mutants (Tables S2, S3, S4, and S5), as described in the Methods section. The features of
the variants which were selected for training are shown in Table 2, and the optimal hyperparameters for the
classifier, chosen by grid search cross-validation, are shown in Table 3.The size of the training set was
limited by the number of known pathogenic missense variants corresponding to phosphosites or their
Hyperparameter Value
Bootstrap True
Criterion Gini
Maximum leaf nodes None
Minimum impurity decrease 1 3 105
Minimum impurity split None
Minimum samples per leaf 1
Minimum samples per split 2
Number of estimators 100
Table 3. Hyperparameters of the Random Forest Classifier
The optimal hyperparameters, selected by grid search cross-validation, for the random forest classifier are shown.
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neighbors. The feature matrices, pre- and post-processing as described in the Methods section, can be
found in Tables S6, S7, S8, S9, S10, S11, S12, and S13.
TheperformanceofPolyPhenandPhosphoEffectwerecomparedona test setof 568benignand600pathogenic
mutants (Tables S14 and S15). PolyPhen had a true-positive rate of 81.2% and a false-positive rate of 25.4%, with
an area under the receiver operating characteristic curve (AUROC) of 0.859. Using a 25% cutoff for false-positive
rate for fair comparison, PhosphoEffect had a true positive rate of 86.3%, with an AUROC of 0.884 (Figure 4).
As with PolyPhen, probability scores associated with a 0%–10% false-positive rate are dubbed ‘‘probably
pathogenic’’ and those with a 10%–20% false-positive rate are ‘‘possibly pathogenic.’’ At this cutoff,
82.7% of pathogenic variants in the test set were assigned ‘‘possibly’’ or ‘‘probably’’ pathogenic, with a
probability threshold of 0.485 for a variant to be classified as possibly or probably pathogenic.
Since the PolyPhen score was used as one of the features to train the classifier, an improvement is to be
expected. When the classifier was trained in the absence of PolyPhen score as a feature, the result was
an AUROC of 0.747, indicating the features used to update the prediction of variants have reasonable pre-
dictive power on their own.
Figure 5 shows the relative importance of the 18 features used to train PhosphoEffect (Table S16). Unsur-
prisingly, given that the aim of the classifier is to update the PolyPhen prediction based on the impact of a
mutation on phosphorylation levels, the PolyPhen score is by far the most important predictor, with a
feature importance of 0.54. The impact of the mutation on phosphorylation level according to NetPhorest
was the second most important 0.10. This supports our hypothesis that the modification of kinase recog-
nition motifs is an important contributor to the pathogenicity of a variant and should be explicitly included
in variant prioritization algorithms.
Structural features of the variant and its neighboring phosphosites were of intermediate importance, but
the network perturbation score is of virtually no importance. This is not surprising because most of the
values for this score are zero, mainly due to the highly incomplete annotation of phosphorylation-depen-
dent PPI, which are challenging to assay on a high-throughput scale and come solely from the curation of
published low-throughput studies.
Figure 2. Performance of PolyPhen on Known Variants
The false-positive (A) and false negative (B) rates of the PolyPhen classifier on phosphorylated residues, residues
neighboring phosphorylation sites, and all others. The error bars indicate standard errors of the proportion. The
difference in false-positive rates between classes was significant (p=2.43310^-9) and the difference in false-negative
rates was marginally significant (p=0.0455). All p-values, including for ad-hoc pairwise testing, are in Table S1.
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Pipeline
We present a pipeline implemented in Python (compatible with versions 3.5 and above) into which the user
can input a tab-delimited text file containing a list of point mutations to query (format UniProtKB accession
number, residue number, wild-type amino acid, mutant amino acid) to obtain a list of classifications along
with associated probabilistic scores. A separate output file logs any errors that are raised during the
running of the pipeline, for instance, if a wild-type residue in the input does not match the canonical
sequence.
Figure 3. NetPhorest Outputs for p53 with Point Mutations at Ser20
(A–C) (A) Wild-type sequence, (B) Mutant S20Y, (C) Mutant S20P.
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DISCUSSION
In this work we have developed a new classifier for the prioritization of missense variants according to their
effect on phosphorylation sites. It takes as a base the score assigned by PolyPhen representing the prob-
ability that the variant is pathogenic and updates this score using a variety of features reflecting the impact
of the mutation on kinase recognition motifs (resulting in the enhancement, disruption, or deregulation of
phosphorylation sites) and the structural and functional impact of such perturbations.
On our testing set, which was enriched for mutations on or around phosphosites, PhosphoEffect incorrectly
classified 17.3% of pathogenic variants as benign, compared with 18.8% for PolyPhen, with a substantially
lower false-positive rate, representing a clear improvement in the accuracy of distinguishing benign and
pathogenic variants.
Additionally, the impact of a mutation on local phosphorylation strength was the second most important
feature in the classifier, after the PolyPhen score. This supports the inclusion of features describing the
direct and indirect impact of mutations on phosphorylation sites, and such an approach could identify large
numbers of clinically relevant mutations that act indirectly through modifying the strength of neighboring
phosphosites, which are overlooked by existing classifiers.
In the era of personalized medicine, where patients with cancer are increasingly having their tumor ge-
nomes sequenced, the identification of novel pathogenic variants could aid in diagnosis, prognosis, and
choice of treatment, as well as targeted drug design. We hope that this computational pipeline will facil-
itate the identification of new potentially deleterious mutations that rewire phosphorylation-dependent
signaling in cancer and can be clinically validated.
Limitations of the Study
However, there remains a lot of work to be done in this area. For instance, our metric for assessing the
impact of mutations on the global PPI network through modification of phosphorylation barely contributed
at all to the performance of the classifier, as for almost all variants this score was zero. This is most likely due
to the scarcity of data on PPI, since iPTMnet is a database curated from evidence from published studies on
individual PPI and phosphorylation sites. Since one of the major roles of phosphorylation events is to alter
PPIs (Nishi et al., 2011) and phosphorylation is central to many disease-related signaling pathways (Ardito
et al., 2017), we do believe that the network-rewiring impact of mutations is crucial to consider when prior-
itizing variants. Future work would entail creating a new model to predict the dependency of a PPI on a
given phosphorylation event, for instance, based on the presence of phosphoprotein binding domains
and their recognition motifs (Guo et al., 2019), which could itself be trained on data from the iPTMnet data-
base and would give a more accurate estimation of the impact of a mutation on the protein-protein
Figure 4. Performance of the PhosphoEffect Compared with PolyPhen on the Test Dataset
Receiver operating characteristic (ROC) curves for (A) PhosphoEffect classifier and (B) PolyPhen; (C) PhosphoEffect
without PolyPhen feature and their respective areas under the curve are 0.884, 0.859, 0.747.
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interaction network. Furthermore, there are many more features that could have been included in the
model, such as the solvent accessibility or number of water contacts per phosphorylated residue—these
may indicate how likely a phosphorylation event is to modify the structure or interactions of a residue.
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 Transparent Methods 
 
Collection of published cancer genome mutations 
 
A dataset of mutations in human cancers was downloaded from COSMIC (Catalogue Of Somatic Mutations 
In Cancer), a comprehensive, manually curated genomic data repository for human cancers (Tate et al. 
2019). The dataset downloaded corresponded only to coding mutations identified in whole genome or whole 
exome sequencing experiments, as opposed to targeted studies, because we were interested in the relative 
frequencies of cancer mutations and targeted experiments are biased towards known cancer-related 
genes. The dataset was filtered to retain only single amino acid point mutations, giving a total of 3,874,127 
mutations corresponding to 19,184 genes and 27,332 tumours. 
 
The mutations were derived from 20 different cancer types. Since some cancer types were greatly 
overrepresented in the dataset due to being more comprehensively studied, we took a random stratified 
sample of 100 tumours from each cancer type. The resulting dataset of 2,000 tumours contained 282,019 
mutations and was used for downstream analysis. 
 
 
Mapping published phosphorylation sites to mutations and enrichment analysis 
 
Annotated phosphorylation sites for the entire human genome were downloaded from PhosphoSitePlus. 
These were then mapped to the COSMIC dataset to determine the number of mutations corresponding to 
phosphorylation sites or their flanking regions (+-5 residues). 
 
Assuming mutations were randomly distributed with respect to phosphorylation sites, the expected number 
of mutations mapping to any given position relative to a phosphosite should be the number of mutations in 
the dataset multiplied by the proportion of all sites in the proteome that are annotated as phosphorylation 
sites. 
 
Since PhosphoSitePlus contains 216,597 annotated phosphosites and the summed length of all proteins 
encoded by unique genes (i.e. excluding splice isoforms or other variants) is 11,222,506, this proportion 
is 0.0193 and our dataset of 282,080 mutations should be expected to contain 5,443 mapping directly to 
phosphosites (and the same number mapping to positions directly up- or downstream of phosphosites, 
with a minor drop-off due to phosphorylations at the N- or C-termini, which was not considered in this 
analysis). Hypergeometric tests were performed to test for significant under- or over enrichment of 
mutations at positions on or neighbouring phosphosites, with Benjamini-Hochberg false discovery rate 
correction for multiple testing. 
 
 
Collection and annotation of known variants 
 
In order to train and test the model we collected a set of variants of known clinical significance and 
annotated them with a range of biophysical and functional features relating to their impact on protein 
phosphorylation. Human genomic variants of known pathogenic significance - either “benign” or 
“pathogenic” - were downloaded from ClinVar (Landrum et al. 2016), focussing only on single amino acid 
missense mutations. A total of 21037 mutations were retrieved (8883 benign and 12154 pathogenic). 
Mutations were classified as class 1 (on phosphosites), class 2 (not on a phosphosite, but within 5 residues 
of a phosphosite), or class 3 (not within 5 residues of a phosphosite). 
 
In order to train our model to detect whether direct or neighbouring phosphorylation is a predictor of 
pathogenicity, our final subset of variants used to train the model - 3000 pathogenic and 2842 benign -  
consisted of a split of two-thirds class 1 and 2, and one-third class 3. While benign variants are much more 
common than pathogenic variants in real genomic datasets, reviews have shown that using a balanced 
training set for binary classifiers gives better predictive power for disease-causing mutations [Wei and 
Dunbrack, 2013]. 
  
Prediction of impact of mutations on phosphorylation pattern 
 
To predict the impact of a mutation on or neighbouring a phosphorylation site on the strength of 
phosphorylation, we used the open-source software NetPhorest 2.1 which uses a neural network/random 
forest hybrid approach to estimate the likelihood of a linear motif being phosphorylated by different classes 
of kinases based on their known targets. The NetPhorest algorithm can be downloaded and queried from 
the command line, taking as input a fasta file and outputting each predicted potential phosphosite, along 
with a series of scores reflecting the estimated probability of the site being phosphorylated by each class 
of kinases, given the five residues up- and downstream of the site. 
 
A Python script was written to download the canonical fasta file of each protein given its accession number 
and to edit the fasta file to incorporate a given point mutation. If one or more annotated phosphorylation 
sites were situated within five residues up-or downstream of the mutation, the canonical (wild-type) and 
edited (mutant) fasta files were queried in NetPhorest. An estimator of the change in phosphorylation 
strength at a given phosphosite incurred by the mutation was calculated as the absolute value of the 
difference of the summed strengths across all kinase classes for the phosphosite in the mutant and wild-
type sequences. For mutations with multiple phosphosites in the +-5 region, the total score for the mutation 
is the sum of the scores for each phosphosite. This is shown in Equation 1 below: 
 
  
 
Where 𝑥𝑘,𝑝,𝑊𝑇 is the recognition strength of kinase k at phosphorylation site p on the wild-type sequence, 
and 𝑥𝑘,𝑝,𝑀 is the strength on mutant M. 
 
Point mutations that occur directly on phosphorylation sites may enhance, decrease or abrogate 
phosphorylation. In the latter case, the impact on local phosphorylation strength will be large; however, 
depending on the properties of the mutant residue, the mutation may mimic constitutive phosphorylation. 
For instance, mutations of threonine to the basic residues aspartate glutamate can have this 
phosphomimetic effect due to the introduction of a negative charge; on the other hand, a tyrosine to 
glutamate mutation is unlikely to mimic tyrosine phosphorylation as the introduction of the negative charge 
will be outweighed by the loss of the bulky benzene ring (Chen and Cole, 2015). For this reason, the 
molecular weight and chemical properties of both the wild-type and mutant residues were included as 
features in the model. 
 
Prediction of impact on protein structure 
 
To assess the impact of a phosphomutation on the structure of the protein, we used the software Residue 
Interaction Network Generator 2.0 (RING 2.0; Piovesan et al. 2016), downloaded with the kind permission 
of the authors, to obtain biophysical features of the phosphosites. Protein Data Bank (PDB) structures for 
proteins were accessed using the ePDB application programmatic interface (API) best_structures tool, 
which ranks all the PDB structures for a given protein by quality (sequence coverage and resolution). We 
sought to identify the highest quality structure which included the residue of interest plus a flanking region 
of at least 5 residues (or up to the terminus for those within 5 residues of the N- or C-terminus); if there 
was no such structure available, we identified the structure with the maximum possible flanking sequence, 
to maximise the likelihood that the residue of interest would be found in its native structure and sequence 
context. The PDB files were fed into the RING software. Given that many PDB structures are of protein 
complexes, we considered only chain-internal contacts between amino acids, and also considered 
contacts between amino acid residues and water molecules. 
 
 From the RING output file, we extracted the secondary structure, degree (number of chain-internal inter-
residue contacts), and the residue-specific all atom-dependent conditional probability distribution function 
(RAPDF), a measure of the thermodynamic stability of the residue (Samudrala and Moult, 1998). For the 
latter two, we calculated a weighted mean for each of the phosphosites within the +5/-5 flanking region of 
the residue of interest, weighted according to the predicted impact of the mutation on the strength of 
phosphorylation as described in the previous section. 
 
Prediction of impact on protein-protein interaction networks 
 
To predict how a mutation would perturb protein-protein interactions (PPIs) through its effect on 
phosphorylation, we used data from iPTMnet, an integrated database for post-translational modifications 
(Huang et al. 2018). iPTMnet, accessible through the Python API pyiptmnet, contains data curated from 
literature evidence of the impact of phosphorylation events on PPIs. Four types of phosphorylation-
dependent association are given: increased association, decreased association, inhibited association, and 
unknown, where there was evidence for an effect of the phosphorylation event on the PPI, but not the 
direction of the effect. In many cases there were multiple sources supporting the dependency of a PPI on 
a given phosphorylation event, and occasionally these had different association types. This was resolved 
by assigning a dependency score to each phosphorylation-dependent association: inhibited association 
was scored as 2; increased or decreased association were scored as 1; and where different sources 
indicated a different association type, the arithmetic mean of these scores was used. A score of 1 was 
assigned when the type of association was unknown. 
 
We used the edge betweenness centrality of a PPI in the global human PPI network as an estimator for its 
importance, and to assess the degree to which a mutation altering phosphorylation would perturb the PPI 
network. Genome-wide PPI data was downloaded from the STRING (Search Tool for the Retrieval of 
INteracting Genes/proteins) database (version 11, Szklarczyk et al. 2019). Associations were filtered to 
include only physical binding interactions (611,087), and Ensembl_PRO IDs were converted to UniProt IDs 
using the human ID mapping database in UniProt, excluding isoform specifications. The interaction data 
was used to reconstruct the global PPI network using the Python module networkx, which contains a range 
of classes and functions for the construction, analysis and visualisation of networks (Hagberg et al. 2008). 
The reconstructed network had 14,527 nodes and 312,626 edges, and from this the betweenness centrality 
of each edge was calculated, defined as the proportion of shortest paths between all node pairs that include 
that edge. 
 
From this, a network perturbation score (NPS) was estimated for each mutation as follows: for each 
phosphorylation site within the +-5 region, a site-specific score was calculated as the sum of the 
dependency score multiplied by the edge betweenness centrality for each PPI dependent on that 
phosphorylation; the overall score for the mutation was calculated as the score for each phosphosite, 
again weighted according to the predicted impact of the mutation on the strength of phosphorylation at 
that site, as in Equation 2 below: 
 
 
Where 
 
 
is the impact of mutation M on phosphorylation site p, and ip are the protein-protein interactions 
dependent on phosphorylation at site p, with dependency δ and edge betweenness centrality ε. 
Where interactions in the iPTMnet database were absent from the STRING-derived network, the EBC 
was imputed as the median EBC for all interactions in the network (3.935 x 10-6). 
 
 Model training and evaluation 
 
Model training and evaluation was carried out using the scikit-learn package for machine learning in 
Python (Pedregosa et al. 2011). The final list of features which were used to train the model are 
shown in Table 2. 
 
All categorical variables were encoded as one-hot dummy variables and quantitative variables were 
scaled to mean 0, variance 1. A random forest classifier was trained on the training set of 4674 
variants, with grid search cross validation used to select the optimal hyperparameters for fitting. In the 
grid search method, different combinations of hyperparameters are sampled, the classifier is fit to the 
training set, and cross-validation is performed; the hyperparameters which result in the best 
performance in cross-validation are then selected. The optimal hyperparameters shown in Table 3. 
 
Receiver operating characteristic (ROC) curves for the random forest classifier and for PolyPhen were 
generated by varying the probability threshold for classification as pathogenic from 0 to 1 in steps of 0.0001, 
and the area under the ROC curve (AUROC) was estimated using the trapezium rule. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Supplementary Figures 
 
 
 
Figure S1, related to Figure 3: the impact score, derived from NetPhorest, of benign and pathogenic 
variants close to phosphorylation sites on the estimated strength of the phosphorylation sites according to 
their kinase recognition motifs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
